Abstract. Manassantin B (MB) is a neolignan isolated fromSaururus chinensis that exhibits a range of activities, including anti-inflammatory, antiseptic and antitumor activity. MB was recently found to affect cell adhesion and expression of several adhesion molecules. Based on the important roles of these adhesion molecules in angiogenesis, we evaluated a possible role for MB in tumor-induced angiogenesis in endothelial cells (ECs). In the present study, we found that MB blocked tumor-induced tube formation of ECs and significantly inhibited the invasion of ECs through the reconstituted basement membrane. MB suppressed the activity of matrix metalloproteinases (MMPs) and downregulated the expression of matrix metalloproteinases 9. Western blotting showed reduction of RUNX2 activation by MB. RUNX2 transcription factor assay and chromatin immunoprecipitation assay showed that the interaction between RUNX2 and target sequences in the matrix metalloproteinases 9 promoters was inhibited by MB. Our findings suggested that the inhibitory effects of MB on tumor-induced angiogenesis were caused by matrix metalloproteinases 9 inhibition, which was associated with the downregulation of RUNX2 transcriptional activity.
IntroductionAngiogenesis, the development of novel blood vessels, is a critical event in many important disease states including ischemic cardiovascular disease, wound healing, inflammation, psoriasis, primary tumor growth and formation of metastases. It is a highly complex process involving endothelial cell (EC) activation, disruption of vascular basement membranes, and migration and proliferation of ECs (1). This process is orchestrated by a large number of cytokines and associated receptors and proteinases, such as vascular endothelial growth factor (VEGF), fibroblast growth factor, interleukin 8 and matrix metalloproteinases (MMPs) (2). Tumor-induced angiogenesis is a process of irregular blood vessel formation, which results in structurally and functionally abnormal blood vessels. This abnormality impairs effective delivery of therapeutic agents to all regions of tumors, it creates abnormal properties of cancer cells, such as survival, resistance of radiation and chemotherapy, and selects for more malignant cells (3). Several decades ago, Dr Folkman proposed anti-angiogenic therapy as an effective method for treatment of cancer (4,5). Nowadays, a number of inhibitors targeting the tumor vasculature have been identified to improve the sensitivity of cancer cells to cytotoxic chemotherapy and other therapeutics (6-8).Saururus chinensis (S. chinensis) is a perennial herbaceous plant that grows wild in moist and shady places throughout East Asia (9). It has a long history of use in China as a folk medicine to remedy various edema, gonorrhea, jaundice and inflammatory diseases (9-11). Previous phytochemical and pharmacological studies on this plant have revealed several types of secondary metabolites, such as lignans, neolignans, aristolactams and flavonoids, as the biologically active compounds (12,13). Numer...